MedImmune set a 'bold' goal in 2007 when it was acquired by AstraZeneca — and it's on track - Washington Business Journal

The Gaithersburg research and development arm of AstraZeneca said it would begin filing a new request for Food and Drug Administration approval for its biologics annually starting this year.